Hepatic lipase: A pro- or anti-atherogenic protein?

Journal of Lipid Research

Volumn 43, Issue 9, 2002, Pages 1352-1362

  Jansen, Hans ^a   Verhoeven, Adrie J M ^a   Sijbrands, Eric J G ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Coronary heart disease; Hyperlipidemia; Lipid homeostasis; Lipoprotein metabolism; Liver; Obesity; Risk factor

Indexed keywords

APOLIPOPROTEIN B100; LIPOPROTEIN; LIPOPROTEIN RECEPTOR; LIVER TRIACYLGLYCEROL LIPASE; TRIACYLGLYCEROL LIPASE;

ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; CORONARY RISK; ENZYME ACTIVITY; HUMAN; LIPID METABOLISM; LIVER METABOLISM; METABOLIC REGULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; CARBOHYDRATE METABOLISM; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY BLOOD VESSEL; DISEASE PREDISPOSITION; ENZYMOLOGY; LIVER; METABOLISM; PATHOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CARBOHYDRATE METABOLISM; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; DISEASE SUSCEPTIBILITY; HUMANS; LIPASE; LIPOPROTEINS; LIVER;

EID: 0036739254     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.R200008-JLR200     Document Type: Review

References (76)

1. Zambon, A., B. G. Brown, S. S. Deeb, and J. D. Brunzell. 2001. Hepatic lipase as a focal point for the development and treatment of coronary artery disease. J. Investig. Med. 49: 112-118.
2. Dugi, K. A., K. Brandauer, N. Schmidt, B. Nau, J. G. Schneider, S. Mentz, T. Keiper, J. R. Schaefer, C. Meissner, H. Kather, M. L. Bahner, W. Fiehn, and J. Kreuzer. 2001. Low hepatic lipase activity is a novel risk factor for coronary artery disease. Circulation. 104: 3057-3062.
3. Perret, B., L. Mabile, L. Martinez, F Tercé, R. Barbaras, and X. Collet. 2002. Hepatic lipase: structure/function relationship, synthesis, and regulation. J. Lipid Res. 43: 1163-1169.
4. Santamarina-Fojo, S., and C. Haudenschild. 2000. Role of hepatic and lipoprotein lipase in lipoprotein metabolism and atherosclerosis: studies in transgenic and knockout animal models and somatic gene transfer. Int. J. Tissue React. 22: 39-47.
5. Connelly, P. W. 1999. The role of hepatic lipase in lipoprotein metabolism. Clin. Chim. Acta. 286: 243-255.
6. Cohen, J. C., G. L. Vega, and S. M. Grundy. 1999. Hepatic lipase: new insights from genetic and metabolic studies. Curr. Opin. Lipidol. 10: 259-267.
7. Berg, A., I. Frey, M. W. Baumstark, M. Halle, and J. Keul. 1994. Physical activity and lipoprotein lipid disorders. Sports Med. 17: 6-21.
8. Kong, C., L. Nimmo, T. Elatrozy, V. Anyaoku, C. Hughes, S. Robinson, W. Richmond, and R. S. Elkeles. 2001. Smoking is associated with increased hepatic lipase activity, insulin resistance, dyslipidaemia and early atherosclerosis in Type 2 diabetes. Atherosclerosis. 156: 373-378.
9. Baynes, C., A. D. Henderson, V. Anyaoku, W. Richmond, C. L. Hughes, D. G. Johnston, and R. S. Elkeles. 1991. The role of insulin insensitivity and hepatic lipase in the dyslipidaemia of type 2 diabetes. Diabet. Med. 8: 560-566.
10. Carr, M. C., J. E. Hokanson, A. Zambon, S. S. Deeb, P. H. Barrett, J. Q. Purnell, and J. D. Brunzell. 2001. The contribution of intraabdominal fat to gender differences in hepatic lipase activity and low/high density lipoprotein heterogeneity. J. Clin. Endocrinol. Metab. 86: 2831-2837.
11. Allayee, H., K. M. Dominguez, B. E. Aouizerat, R. M. Krauss, J. I. Rotter, J. Lu, R. M. Cantor, T. W. de Bruin, and A. J. Lusis. 2000. Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia. J. Lipid Res. 41: 245-252.
12. Moriguchi, E. H., H. Tamachi, and Y. Goto. 1990. Hepatic lipase activity and high density lipoproteins in familial hypercholesterolemia: adaptational mechanisms for LDL-receptor deficient state. Tokai J. Exp. Clin. Med. 15: 401-406.
13. Dugi, K. A., I. M. Feuerstein, S. Hill, J. Shih, S. Santamarina-Fojo, H. B. Brewer, Jr., and J. M. Hoeg. 1997. Lipoprotein lipase correlates positively and hepatic lipase inversely with calcific atherosclerosis in homozygous familial hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 17: 354-364.
14. Barth, J. D., H. Jansen, D. Kromhout, J. H. Reiber, J. C. Birkenhager, and A. C. Arntzenius. 1987. Progression and regression of human coronary atherosclerosis. The role of lipoproteins, lipases and thyroid hormones in coronary lesion growth. Artherosclerosis. 68: 51-58.
15. Groot, P. H., W. A. van Stiphout, X. H. Krauss, H. Jansen, A. van Tol, E. van Ramshorst, S. Chin-On, A. Hofman, S. R. Cresswell, and L. Havekes. 1991. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler. Thromb. 11: 653-662.
16. Zambon, A., S. S. Deeb, A. Bensadoun, K. E. Foster, and J. D. Brunzell. 2000. In vivo evidence of a role for hepatic lipase in human apoB-containing lipoprotein metabolism, independent of its lipolytic activity. J. Lipid Res. 41: 2094-2099.
17. Hoogerbrugge, N., and H. Jansen. 1999. Atorvastatin increases low-density lipoprotein size and enhances high-density lipoprotein cholesterol concentration in male, but not in female patients with familial hypercholesterolemia. Atherosclerosis. 146: 167-174.
18. Jansen, H., A. J. Verhoeven, L. Weeks, J. J. Kastelein, D. J. Halley, A. van den Ouweland, J. W. Jukema, J. C. Seidell, and J. C. Birkenhager. 1997. Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler. Thromb. Vasc. Biol. 17: 2837-2842.
19. Zambon, A., J. E. Hokanson, B. G. Brown, and J. D. Brunzell. 1999. Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density. Circulation. 99: 1959-1964.
20. Connelly, P. W., and R. A. Hegele. 1998. Hepatic lipase deficiency. Crit. Rev. Clin. Lab. Sci. 35: 547-572.
21. Guerra, R., J. Wang, S. M. Grundy, and J. C. Cohen. 1997. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc. Natl. Acad. Sci. USA. 94: 4532-4537.
22. Shohet, R. V., G. L. Vega, A. Anwar, J. E. Cigarroa, S. M. Grundy, and J. C. Cohen. 1999. Hepatic lipase (LIPC) promoter polymorphism in men with coronary artery disease. Allele frequency and effects on hepatic lipase activity and plasma HDL-C concentrations. Arterioscler. Thromb. Vasc. Biol. 19: 1975-1978.
23. Andersen, R. V., H. H. Wittrup, A. Tybjaerg-Hansen, R. Steffensen, P. Schnohr, and B. G. Nordesgaard. 2001. Hepatic lipase promoter SNPs associated with increased HDL cholesterol and paradoxically an increased risk of ischemic heart disease: the copenhagen city heart study. Atherosclerosis. Supplement 2, Abstract W12.1.
24. Fan, Y., R. Laaksonen, T. Janatuinen, R. Vesalainen, P. Nuutila, T. Koivula, J. Knuuti, and T. Lehtimaki. 2001. Hepatic lipase gene variation is related to coronary reactivity in healthy young men. Eur. J. Clin. Invest. 31: 574-580.
25. Hakonson, J. E., S. Cheng, J. K. Snell-Bergeon, B. A. Fijal, M. A. Grow, C. Hung, H. A. Erlich, J. Erlich, R. H. Eckel, and M. Rewers. 2002. A common promoter polymorphism in the hepatic lipase gene (LIPC-480C>T) is associated with an increase in coronary calcification in type 1 diabetes. Diabetes. 51: 1208-1213.
26. Hirano, K., S. Yamashita, Y. Kuga, N. Sakai, S. Nozaki, S. Kihara, T. Arai, K. Yanagi, S. Takami, M. Menju, M. Ishigama, Y. Yoshida, K. Kameda-Takemura, K. Hayashi, and Y. Matsuzawa. 1995. Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase. Arterioscler. Thromb. Vasc. Biol. 15: 1849-1856.
27. Vega, G. L., L. T. Clark, A. Tang, S. Marcovina, S. M. Grundy, and J. C. Cohen. 1998. Hepatic lipase activity is lower in African American men than in white American men: effects of 5′ flanking polymorphism in the hepatic lipase gene (LIPC). J. Lipid Res. 39: 228-232.
28. Zambon, A., S. S. Deeb, J. E. Hokanson, B. G. Brown, and J. D. Brunzell. 1998. Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol. Arterioscler. Thromb. Vasc. Biol. 18: 1723-1729.
29. Busch, S. J., R. L. Barnhart, G. A. Martin, M. C. Fitzgerald, M. T. Yates, S. J. Mao, C. E. Thomas, and R. L. Jackson. 1994. Human hepatic triglyceride lipase expression reduces high density lipoprotein and aortic cholesterol in cholesterol-fed transgenic mice. J. Biol. Chem. 269: 16376-16382.
30. Weng, W., N. A. Brandenburg, S. Zhong, J. Halkias, L. Wu, X. C. Jiang, A. Tall, and J. L. Breslow. 1999. ApoA-II maintains HDL levels in part by inhibition of hepatic lipase. Studies In apoA-II and hepatic lipase double knockout mice. J. Lipid Res. 40: 1064-1070.
31. Hedrick, C. C., L. W. Castellani, H. Wong, and A. J. Lusis. 2001. In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions. J. Lipid Res. 42: 563-570.
32. Mezdour, H., R. Jones, C. Dengremont, G. Castro, and N. Maeda. 1997. Hepatic lipase deficiency increases plasma cholesterol but reduces susceptibility to atherosclerosis in apolipoprotein E-deficient mice. J. Biol. Chem. 272: 13570-13575.
33. Taylor J. M. 1997. Transgenic rabbit models for the study of atherosclerosis. Front. Biosci. 2: D298-308.
34. Jansen, H., A. van Tol, J. Auwerx, G. Skretting, and B. Staels. 1992. Opposite regulation of hepatic lipase and lecithin: cholesterol acyltransferase by glucocorticoids in rats. Biochim. Biophys. Acta. 1128: 181-185.
35. Cohen, J. C., Z. Wang, S. M. Grundy, M. R. Stoesz, and R. Guerra. 1994. Variation at the hepatic lipase and apolipoprotein AI/CIII/ AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J. Clin. Invest. 94: 2377-2384.
36. Hegele, R. A., S. B. Harris, J. H. Brunt, T. K. Young, A. J. Hanley, B. Zinman, and P. W. Connelly. 1999. Absence of association between genetic variation in the LIPC gene promoter and plasma lipoproteins in three Canadian populations. Atherosclerosis. 146: 153-160.
37. Navab, M., S. Y. Hama, G. P. Hough, C. C. Hedrick, R. Sorenson, B. N. La Du, J. A. Kobashigawa, G. C. Fonarow, J. A. Berliner, H. Laks, and A. M. Fogelman. 1998. High density associated enzymes: their role in vascular biology. Curr. Opin. Lipidol. 9: 449-456.
38. Jansen, H., and W. C. Hulsmann. 1980. Heparin-releasable (liver) lipase(s) may play a role in the uptake of cholesterol by steroidsecreting tissues. Trends Biochem. Sci. 5: 265-268.
39. Johnson, W. J., M. J. Bamberger, R. A. Latta, P. E. Rapp, M. C. Phillips, and G. H. Rothblat. 1986. The bidirectional flux of cholesterol between cells and lipoproteins. Effects of phospholipid depletion of high density lipoprotein. J. Biol. Chem. 261: 5766-5776.
40. Lambert, G., M. J. Amar, P. Martin, J. Fruchart-Najib, B. Foger, R. D. Shamburek, H. B. Brewer, Jr., and S. Santamarina-Fojo. 2000. Hepatic lipase deficiency decreases the selective uptake of HDL-cholesteryl esters in vivo. J. Lipid Res. 41: 667-672.
41. Lambert, G., M. B. Chase, K. Dugi, A. Bensadoun, H. B. Brewer, Jr., and S. Santamarina-Fojo. 1999. Hepatic lipase promotes the selective uptake of high density lipoprotein-cholesteryl esters via the scavenger receptor B1. J. Lipid Res. 40: 1294-1303.
42. Collet, X., A. R. Tall, H. Serajuddin, K. Guendouzi, L. Royer, H. Oliveira, R. Barbaras, X. C. Jiang, and O. L. Francone. 1999. Remodeling of HDL by CETP in vivo and by CETP and hepatic lipase in vitro results in enhanced uptake of HDL CE by cells expressing scavenger receptor B-I. J. Lipid Res. 40: 1185-1193.
43. Ueda, Y., L. Royer, E. Gong, J. Zhang, P. N. Cooper, O. Francone, and E. M. Rubin. 1999. Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B type I transgenic mice. J. Biol. Chem. 274: 7165-7171.
44. Fielding, C. J., and P. E. Fielding. 2001. Cellular cholesterol efflux. Biochim. Biophys. Acta. 1533: 175-189.
45. von Eckardstein, A., J. R. Nofer, and G. Assmann. 2000. Acceleration of reverse cholesterol transport. Curr. Opin. Cardiol. 15: 348-354.
46. von Eckardstein, A., J. R. Nofer, and G. Assmann. 2001. High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport. Arterioscler. Thromb. Vasc. Biol. 21: 13-27.
47. Hill, S. A., and M. J. McQueen. 1997. Reverse cholesterol transport-a review of the process and its clinical implications. Clin Biochem. 30: 517-525.
48. Nofer, J. R., B. Kehrel, M. Fobker, B. Levkau, G. Assmann, and A. Eckardstein. 2002. HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis. 161: 1-16.
49. Ginsberg, H. N. 1996. Diabetic dyslipidemia: basic mechanisms underlying the common hypertriglyceridemia and low HDL cholesterol levels. Diabetes. 45(Suppl. 3): S27-30.
50. Demant, T., L. A. Carlson, L. Holmquist, F. Karpe, P. Nilsson-Ehle, C. J. Packard, and J. Shepherd. 1988. Lipoprotein metabolism in hepatic lipase deficiency: studies on the turnover of apolipoprotein B and on the effect of hepatic lipase on high density lipoprotein. J. Lipid Res. 29: 1603-1611.
51. Jansen, H., G. Chu, C. Ehnholm, J. Dallongeville, V. Nicaud, and P. J. Talmud. 1999. The T allele of the hepatic lipase promoter variant C-480T is associated with increased fasting lipids and HDL and increased preprandial and postprandial LpCIII:B: European Atherosclerosis Research Study (EARS) II. Arterioscler. Thromb. Vasc. Biol. 19: 303-308.
52. Asami, T., T. Ciomartan, and M. Uchiyama. 1999. Thyroxine inversely regulates serum intermediate density lipoprotein levels in children with congenital hypothyroidism. Pediatr. Int. 41: 266-269.
53. Krauss, R. M. 1987. Relationship of intermediate and low-density lipoprotein subspecies to risk of coronary artery disease. Am. Heart J. 113: 578-582.
54. Havel, R. J. 2000. Genetic underpinnings of LDL size and density: a role for hepatic lipase? Am. J. Clin. Nutr 71: 1390-1391.
55. Austin, M. A., P. J. Talmud, L. A. Luong, L. Haddad, I. N. Day, B. Newman, K. L. Edwards, R. M. Krauss, and S. E. Humphries. 1998. Candidate-gene studies of the atherogenic lipoprotein phenotype: a sib-pair linkage analysis of DZ women twins. Am. J. Hum. Genet. 62: 406-419.
56. Austin, M. A., K. Stephens, C. E. Walden, and E. Wijsman. 1999. Linkage analysis of candidate genes and the small, dense low-density lipoprotein phenotype. Atherosclerosis. 142: 79-87.
57. Jansen, H., W. Hop, A. van Tol, A. V. Bruschke, and J. C. Birkenhager. 1994. Hepatic lipase and lipoprotein lipase are not major determinants of the low density lipoprotein subclass pattern in human subjects with coronary heart disease. Atherosclerosis. 107: 45-54.
58. Yu, K. C., and A. D. Cooper. 2001. Postprandial lipoproteins and atherosclerosls. Front. Biosci. 6: D332-354.
59. Fan, J., J. Wang, A. Bensadoun, S. J. Lauer, Q. Dang, R. W. Mahley, and J. M. Taylor. 1994. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc. Natl. Acad. Sci. USA. 91: 8724-8728.
60. Pihlajamaki, J., L. Karjalainen, P. Karhapaa, I. Vauhkonen, M. R. Taskinen, S. S. Deeb, and M. Laakso. 2000. G-250A substitution in promoter of hepatic lipase gene is associated with dyslipidemia and insulin resistance in healthy control subjects and in members of families with familial combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 20: 1789-1795.
61. Jansen, H., D. M. Waterworth, V. Nicaud, C. Ehnholm, and P. J. Talmud. 2001. Interaction of the common apolipoprotein C-III (APOC3-482C > T) and hepatic lipase (LIPG-514C > T) promoter variants affects glucose tolerance in young adults. European Atherosclerosis Research Study II (EARS-II). Ann. Hum. Genet. 65: 237-243.
62. Baynes, C., A. D. Henderson, V. Anyaoku, W. Richmond, D. G. Johnston, and R. S. Elkeles. 1991. The influence of regional adiposity on atherogenic risk factors in men and women with type 2 diabetes. Diabet. Med. 8: 458-463.
63. Purnell, J. Q., S. E. Kahn, J. J. Albers, D. N. Nevin, J. D. Brunzell, and R. S. Schwartz. 2000. Effect of weight loss with reduction of intra-abdominal fat on lipid metabolism in older men. J. Clin. Endocrinol. Metab. 85: 977-982.
64. Huuskonen, J., and C. Ehnholm. 2000. Phospholipid transfer protein in lipid metabolism. Curr. Opin. Lipidol. 11: 285-289.
65. van Tol, A. 2002. Phospholipid transfer protein. Curr. Opin. Lipidol. 13: 135-139.
66. Vieira-van Bruggen, D., I. Kalkman, T. van Gent, A. van Tol, and H. Jansen. 1998. Induction of adrenal scavenger receptor BI and increased high density lipoprotein-cholesteryl ether uptake by in vivo inhibition of hepatic lipase. J. Biol. Chem. 273: 32038-32041.
67. Wang, N., W. Weng, J. L. Breslow, and A. R. Tall. 1996. Scavenger receptor BI (SR-BI) is up-regulated in adrenal gland in apolipoprotein A-I and hepatic lipase knock-out mice as a response to depletion of cholesterol stores. In vivo evidence that SR-BI is a functional high density lipoprotein receptor under feedback control. J. Biol. Chem. 271: 21001-21004.
68. Jansen, H., and W. J. de Greef. 1988. L-type lipase activity in ovaries of superovulated rats. Relation to cholesterol homeostasis. Mol. Cell. Endocrinol. 57: 7-15.
69. Jansen, H. 1985. Inhibition of liver lipase in vivo leads to induction of de novo cholesterol synthesis in rat liver. Biochem. Biophys. Res. Commun. 131: 574-578.
70. Busch, S. J., R. L. Barnhart, G. A. Martin, M. A. Flanagan, and R. L. Jackson. 1990. Differential regulation of hepatic triglyceride lipase and 3-hydroxy-3-methylglutaryl-CoA reductase gene expression in a human hepatoma cell line, HepG2. J. Biol. Chem. 265: 22474-22479.
71. Busch, S. J., G. A. Martin, R. L. Barnhart, M. A. Flanagan, and R. L. Jackson. 1991. Regulation of hepatic lipase expression by an intermediate of the cellular cholesterol biosynthetic pathway. Adv. Exp. Med. Biol. 285: 65-69.
72. Botma, G. J., A. J. Verhoeven, and H. Jansen. 2001. Molecular basis of the association between hepatic lipase activity and obesity, hypertriglyceridemia and insulin resistance. Circulation. American Heart Association meeting, Anaheim, California. 2001
73. Goldstein, J. L., R. B. Rawson, and M. S. Brown. 2002. Mutant mammalian cells as tools to delineate the sterol regulatory element-binding protein pathway for feedback regulation of lipid synthesis. Arch. Biochem. Biophys. 397: 139-148.
74. Croston, G. E., L. B. Milan, K. B. Marschke, M. Reichman, and M. R. Briggs. 1997. Androgen receptor-mediated antagonism of estrogen-dependent low density lipoprotein receptor transcription in cultured hepatocytes. Endocrinology. 138: 3779-3786.
75. Nimmo, L., A. J. McColl, J. Z. Rosankiewicz, W. Richmond, and R. S. Elkeles. 1997. Regulation of hepatic lipase expression in HepG2 cells. Biochem. Soc. Trans. 25: S689.
76. Sul, H. S., M. J. Latasa, Y. Moon, and K. H. Kim. 2000. Regulation of the fatty acid synthase promoter by insulin. J. Nutr. 130: 315S-320S.